Preventive cardiac screening is a comprehensive heart health evaluation aimed at detecting cardiovascular disease at an early stage, even before symptoms develop. Many heart conditions such as coronary artery disease, hypertension, rhythm disorders, and heart muscle weakness can remain silent for years and may first present as a heart attack or sudden cardiac event. Preventive screening helps identify risk factors early and allows timely treatment and lifestyle modification to reduce future heart-related complications.

Hypertension, commonly known as high blood pressure, is one of the most common cardiovascular conditions affecting adults worldwide. It is often called a “silent killer” because many patients may not experience symptoms for years while the elevated blood pressure gradually damages important organs such as the heart, brain, kidneys, eyes, and blood vessels. If left untreated, hypertension can increase the risk of heart attack, stroke, heart failure, kidney failure, and other serious complications.

Cholesterol management is an important part of preventing and treating heart disease, stroke, and blood vessel blockages. Excess “bad cholesterol,” known as LDL cholesterol, can gradually build up inside the arteries and form plaques, leading to narrowing of blood vessels and reduced blood flow to the heart and other organs. Over time, this can result in heart attack, stroke, peripheral artery disease, or worsening cardiovascular health if not properly controlled.

Diabetes and obesity are two major health conditions that significantly increase the risk of heart disease, high blood pressure, stroke, heart failure, and blood vessel blockages. Excess body weight and uncontrolled blood sugar can gradually damage the heart, blood vessels, kidneys, and other organs over time.

Chemotherapy-induced cardiotoxicity refers to damage or weakening of the heart caused by certain cancer treatments. While chemotherapy and other cancer therapies play a vital role in treating cancer, some medications can affect the heart muscle, heart valves, blood pressure, or heart rhythm in certain patients. Early detection and monitoring of heart function are extremely important because many cardiac complications can be identified and managed before permanent damage occurs.

Certain chemotherapy drugs and cancer treatments can affect the heart and blood vessels during or after cancer therapy. Cardiac monitoring during chemotherapy is an important part of modern cardio-oncology care and helps detect early changes in heart function before serious complications develop. Regular monitoring allows timely treatment and helps patients continue cancer therapy more safely while protecting long-term heart health.

Cancer therapy–related cardiac dysfunction refers to weakening or damage to the heart that may occur as a side effect of certain chemotherapy drugs, targeted therapies, immunotherapy, or radiation treatment. While modern cancer therapies have significantly improved survival, some treatments can affect the heart muscle, heart valves, blood vessels, blood pressure, or heart rhythm.